These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29398275)

  • 1. The impact of expanded program on immunization with live attenuated and inactivated Hepatitis A vaccines in China, 2004-2016.
    Sun X; Wang F; Zheng H; Miao N; Yuan Q; Cui F; Yin Z; Zhang G; Levine H
    Vaccine; 2018 Feb; 36(10):1279-1284. PubMed ID: 29398275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China - A cross-sectional study.
    Xiaojin S; Rodewald LE; Guomin Z; Hui Z; Ning M; Fuzhen W; Zundong Y
    Vaccine; 2020 Dec; 38(52):8302-8309. PubMed ID: 33213930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis A vaccination coverage among adolescents (13-17 years) in the United States, 2008-2016.
    Nelson NP; Yankey D; Singleton JA; Elam-Evans LD
    Vaccine; 2018 Mar; 36(12):1650-1659. PubMed ID: 29449100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the epidemiology of hepatitis A in three socio-economic regions of China, 1990-2017.
    Sun XJ; Zhang GM; Zhou RJ; Zheng H; Miao N; Yin ZD; Wang FZ
    Infect Dis Poverty; 2019 Oct; 8(1):80. PubMed ID: 31578150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live attenuated hepatitis A vaccines developed in China.
    Xu ZY; Wang XY
    Hum Vaccin Immunother; 2014; 10(3):659-66. PubMed ID: 24280971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005-2018.
    Guo Y; Zhang L; Feng D; Zhao S; Liu Q; Xu J; Lu M; Li J; Zhang Y; Guo W
    Int J Infect Dis; 2020 Apr; 93():163-167. PubMed ID: 32045695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immunogenicity and impact factors of hepatitis A attenuated live vaccine and inactivated vaccine].
    Zheng H; Cui FQ
    Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):371-4. PubMed ID: 20077742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.
    Yan BY; Lv JJ; Liu JY; Feng Y; Wu WL; Xu AQ; Zhang L
    Int J Infect Dis; 2019 May; 82():129-134. PubMed ID: 30862519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)].
    Li JP; Gao ZX; Zhou J
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):238-40. PubMed ID: 20726266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of antibody persistence between live attenuated and inactivated hepatitis A vaccines].
    Liu HF; Zhang XJ; Zhang JL
    Zhongguo Yi Miao He Mian Yi; 2009 Aug; 15(4):300-3. PubMed ID: 20077725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Immunogenicity Between Inactivated and Live Attenuated Hepatitis A Vaccines Among Young Adults: A 3-Year Follow-up Study.
    Liu XE; Chen HY; Liao Z; Zhou Y; Wen H; Peng S; Liu Y; Li R; Li J; Zhuang H
    J Infect Dis; 2015 Oct; 212(8):1232-6. PubMed ID: 25969561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing Epidemiology of Hepatitis A in China: Evidence From Three National Serological Surveys and the National Notifiable Disease Reporting System.
    Wang F; Sun X; Wang F; Zheng H; Jia Z; Zhang G; Bi S; Miao N; Zhang S; Cui F; Li L; Wang H; Liang X; Rodewald LE; Feng Z; Yin Z; Shen L
    Hepatology; 2021 Apr; 73(4):1251-1260. PubMed ID: 32592242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The coverage of hepatitis A vaccine among 2-29 year olds and the reporting incidence of hepatitis A in China, 2014].
    Wang FZ; Zheng H; Liu JH; Sun XJ; Miao N; Shen LP; Zhang GM; Cui FQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1099-104. PubMed ID: 27539340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation on the effect of immunization and safety of live attenuated and inactivated hepatitis A vaccine in China].
    Li H; Zhang XS; An J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jan; 34(1):24-7. PubMed ID: 23648244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    Wang Z; Chen Y; Xie S; Lv H
    PLoS One; 2016; 11(4):e0153804. PubMed ID: 27093614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation and analysis of antibody levels of hepatitis A among children before and after implementing the Expanded National Immunization Program in China.
    Xu WB; Li Y; Li D; Fang Y; An ZJ; Teng X; Wang HQ; Shang QL
    Vaccine; 2020 Jan; 38(4):878-881. PubMed ID: 31733948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A vaccination.
    Zhang L
    Hum Vaccin Immunother; 2020 Jul; 16(7):1565-1573. PubMed ID: 32649265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study.
    Luo J; Wang X; Ma F; Kang G; Ding Z; Ye C; Pan Y; Zhao Y; Hong S; Chen J; Xi J; Wen S; Lin Y; Li X; Qiu L; Yang X; Li G; Yang J; Sun Q
    Clin Microbiol Infect; 2019 Nov; 25(11):1422-1427. PubMed ID: 30496870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.